cyclacel.com (BGMS) - יתרות מזומנים למניה אחת

סמל תאגידי ולוגו של Cyclacel (BGMS)

Bio Green Med Solution Inc is attracting leading scientists to develop targeted therapies, leveraging agile management and stock option programs. The cash per share trend illustrates financial stability, with the value of 0.52 serving as the current metric. Business valuation growth depends on the success of Fadracyclbine, while binary portfolio risks are mitigated through the use of contract research.

cyclacel.com (BGMS) - מזומנים למניה אחת מ-13.09.2025 עד 20.11.2026

פילוחי מדדים מקיפים ואנליטיקה עבור Cyclacel (BGMS)

- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח מקיף של החברה:Cyclacel Pharmaceuticals - BGMS
סחורת הדגל של Cyclacel Pharmaceuticals

Investors constantly balance potential profit against the risk of capital loss. This indicator compares liquid reserve volumes with the number of shares to determine the "cash cushion" per share. By analyzing the cash-per-share structure, one can assess the issuer's financial resilience to market shocks. For Bio Green Med Solution Inc (BGMS), this reserve is critical, as the development of kinase inhibitors requires massive expenditures prior to the completion of clinical trials. A decline in this metric signals a reduction in resources available to bring drugs to market.